165 related articles for article (PubMed ID: 32586113)
1. Sodium valproate prescription to women of childbearing age in a New Zealand inpatient psychiatric unit.
Goldspink R; Pumipi T; Dey S; Menkes DB
Australas Psychiatry; 2020 Oct; 28(5):555-558. PubMed ID: 32586113
[TBL] [Abstract][Full Text] [Related]
2. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.
Paton C; Cookson J; Ferrier IN; Bhatti S; Fagan E; Barnes TRE
BMJ Open; 2018 Apr; 8(4):e020450. PubMed ID: 29654033
[TBL] [Abstract][Full Text] [Related]
3. Brief intervention reduces prescription of sodium valproate in women of childbearing age.
Goldspink R; Pumipi T; Menkes DB
Australas Psychiatry; 2023 Aug; 31(4):524-527. PubMed ID: 37035997
[TBL] [Abstract][Full Text] [Related]
4. 'Conceivably Neglected' - Are prescribers sufficiently aware of the risks of prescribing sodium valproate to women with mental illness?
Perera C; Patterson S; Bruxner G
Australas Psychiatry; 2019 Apr; 27(2):125-128. PubMed ID: 30763123
[TBL] [Abstract][Full Text] [Related]
5. Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study.
Gaudio M; Konstantara E; Joy M; van Vlymen J; de Lusignan S
BMC Pregnancy Childbirth; 2022 Jan; 22(1):73. PubMed ID: 35086478
[TBL] [Abstract][Full Text] [Related]
6. Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
Macfarlane A; Greenhalgh T
BMC Pregnancy Childbirth; 2018 Jun; 18(1):200. PubMed ID: 29859057
[TBL] [Abstract][Full Text] [Related]
7. Use of valproate in women of childbearing potential: pre- and post-NICE bipolar guidelines.
Vasudev K; Mead A
Arch Womens Ment Health; 2010 Aug; 13(4):371-2. PubMed ID: 20440523
[No Abstract] [Full Text] [Related]
8. [Prescribing valproate to girls and women of childbearing age in Germany : Analysis of trends based on claims data].
Wentzell N; Haug U; Schink T; Engel S; Liebentraut J; Linder R; Onken M; Schaefer C; Dathe K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Aug; 61(8):1022-1029. PubMed ID: 29922910
[TBL] [Abstract][Full Text] [Related]
9. Valproate in acute mania: is our practice evidence based?
Vasudev K; Mead A; Macritchie K; Young AH
Int J Health Care Qual Assur; 2012; 25(1):41-52. PubMed ID: 22455007
[TBL] [Abstract][Full Text] [Related]
10. Valproate prescription prevalence among women of childbearing age.
Wisner KL; Leckman-Westin E; Finnerty M; Essock SM
Psychiatr Serv; 2011 Feb; 62(2):218-20. PubMed ID: 21285103
[TBL] [Abstract][Full Text] [Related]
11. Should women of childbearing potential be prescribed valproate? a call to action.
Balon R; Riba M
J Clin Psychiatry; 2016 Apr; 77(4):525-6. PubMed ID: 27137420
[TBL] [Abstract][Full Text] [Related]
12. Preventive recommendations on the use of valproic acid in pregnant or gestational women to be very present.
García-Portilla MP; Bobes J
Rev Psiquiatr Salud Ment; 2017; 10(3):129-133. PubMed ID: 28688547
[No Abstract] [Full Text] [Related]
13. Informing patients of the teratogenic potential of mood stabilizing drugs: a case note review of the practice of psychiatrists.
James L; Barnes TR; Lelliott P; Taylor D; Paton C
J Psychopharmacol; 2007 Nov; 21(8):815-9. PubMed ID: 17881432
[TBL] [Abstract][Full Text] [Related]
14. Valproic Acid in Women and Girls of Childbearing Age.
Gotlib D; Ramaswamy R; Kurlander JE; DeRiggi A; Riba M
Curr Psychiatry Rep; 2017 Sep; 19(9):58. PubMed ID: 28726062
[TBL] [Abstract][Full Text] [Related]
15. Prescription of sodium valproate to women of childbearing potential in Southern District Mental Health Services in New Zealand.
Corfe-Tan J; McLay L; Mentzel C
Australas Psychiatry; 2023 Dec; 31(6):776-781. PubMed ID: 37632171
[TBL] [Abstract][Full Text] [Related]
16. Changes in sodium valproate dispensing in women of childbearing age with a diagnosis of borderline personality disorder in Aotearoa New Zealand.
Tennant M; Frampton C; Mulder R; Eggleston K; Beaglehole B
N Z Med J; 2024 Jun; 137(1597):36-43. PubMed ID: 38901047
[TBL] [Abstract][Full Text] [Related]
17. A review of valproate in psychiatric practice.
Haddad PM; Das A; Ashfaq M; Wieck A
Expert Opin Drug Metab Toxicol; 2009 May; 5(5):539-51. PubMed ID: 19409030
[TBL] [Abstract][Full Text] [Related]
18. Sodium valproate and the fetus: a case study and review of the literature.
Smith J; Whitehall J
Neonatal Netw; 2009; 28(6):363-7. PubMed ID: 19892633
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Perinatal Women Attending a Mother and Baby Unit Taking Sodium Valproate or Lithium with a Diagnosis of Bipolar Affective Disorder.
Lebedevs T; Gan M; Teoh SWK; Brown P
Psychiatr Q; 2020 Sep; 91(3):695-701. PubMed ID: 32157548
[TBL] [Abstract][Full Text] [Related]
20. Sodium valproate induced acute pancreatitis in a bipolar disorder patient: a case report.
Huang W; Ren X; Shen F; Xing B
BMC Pharmacol Toxicol; 2019 Nov; 20(1):71. PubMed ID: 31783774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]